Protocol Ledger

NCT04633122 · Phase II · COMPLETED

A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib

Interventional Phase II clinical trial protocol NCT04633122 sponsored by Zai Lab (Shanghai) Co in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-11-25 Enrollment: 108 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04633122
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)108 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04633122
Protocol FieldVerified Registry Value
NCT IdentifierNCT04633122
Consolidated Lead SponsorZai Lab (Shanghai) Co
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment108 participants (ACTUAL)
Registered Start Date2020-11-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI